Treventis Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $490K

  • Investors
  • 7

Treventis General Information

Description

Developer of disease-modifying small molecule drugs designed to identify the molecule that can enter the brain and neutralize both misfolded proteins. The company's drugs can identify compounds that potently block the progression of amyloid toxicity, enabling physicians to treat Alzheimer's patients without any side effects.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 60 Leonard Avenue 4KD472
  • Toronto, Ontario M5T 0S8
  • Canada
+1 (416)
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 60 Leonard Avenue 4KD472
  • Toronto, Ontario M5T 0S8
  • Canada
+1 (416)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Treventis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Jan-2023 $490K Completed Pre-Clinical Trials
5. Grant 18-Oct-2022 Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Feb-2017 Completed Pre-Clinical Trials
3. Accelerator/Incubator 21-Jan-2016 Completed Pre-Clinical Trials
2. Seed Round 30-Jul-2012 $4.41M $4.96M Completed Pre-Clinical Trials
1. Seed Round 10-Aug-2009 $550K $550K Completed Pre-Clinical Trials
To view Treventis’s complete valuation and funding history, request access »

Treventis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of disease-modifying small molecule drugs designed to identify the molecule that can enter the brain and neutr
Drug Discovery
Toronto, Canada
18 As of 2026

New York, NY
 

Framingham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Treventis Competitors (7)

One of Treventis’s 7 competitors is Cognition Therapeutics, a Formerly VC-backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cognition Therapeutics Formerly VC-backed New York, NY
Alzheon Venture Capital-Backed Framingham, MA
Neurimmune Formerly Accelerator/Incubator backed Zurich, Switzerland
NMD Pharma Venture Capital-Backed Aarhus, Denmark
ProMIS Neurosciences Corporation Toronto, Canada
You’re viewing 5 of 7 competitors. Get the full list »

Treventis Patents

Treventis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230357154-A1 Butyrylcholinesterase compounds and use in diseases of the nervous system Pending 08-Aug-2019
WO-2021026429-A1 Butyrylcholinesterase compounds and use in diseases of the nervous system Inactive 08-Aug-2019
AU-2015222903-A1 Anti-amyloid compounds containing benzofurazan Active 27-Feb-2014
AU-2015222903-B2 Anti-amyloid compounds containing benzofurazan Active 27-Feb-2014
CA-2977360-A1 Anti-amyloid compounds containing benzofurazan Active 27-Feb-2014 C07D271/12
To view Treventis’s complete patent history, request access »

Treventis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Treventis Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
United States Department of War Government
Congressionally Directed Medical Research Programs Government
Johnson & Johnson Innovation - JLABS Accelerator/Incubator
Invest Nova Scotia Venture Capital Minority
Life Sciences Nova Scotia Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

Treventis FAQs

  • When was Treventis founded?

    Treventis was founded in 2008.

  • Where is Treventis headquartered?

    Treventis is headquartered in Toronto, Canada.

  • What is the size of Treventis?

    Treventis has 18 total employees.

  • What industry is Treventis in?

    Treventis’s primary industry is Drug Discovery.

  • Is Treventis a private or public company?

    Treventis is a Private company.

  • What is Treventis’s current revenue?

    The current revenue for Treventis is .

  • How much funding has Treventis raised over time?

    Treventis has raised $5.06M.

  • Who are Treventis’s investors?

    United States Department of War, Congressionally Directed Medical Research Programs, Johnson & Johnson Innovation - JLABS, Invest Nova Scotia, and Life Sciences Nova Scotia are 5 of 7 investors who have invested in Treventis.

  • Who are Treventis’s competitors?

    Cognition Therapeutics, Alzheon, Neurimmune, NMD Pharma, and ProMIS Neurosciences are some of the 7 competitors of Treventis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process